The new focus area "Single Cell Technologies for Personalized Medicine", jointly established by BIH, MDC and Charité, aims at building bridges between basic and clinical research to make highly innovative single cell technologies clinically usable for effective translation as quickly as possible. For this purpose, the Berlin Institute of Health (BIH) and the Berlin Institute for Medical Systems Biology (BIMSB) of the MDC are recruiting three leaders for so-called bridge junior research groups that bring single cell expertise into clinical application.
In the new focus area, the future junior research group leaders will aim to understand how human diseases arise and progress at the single cell level in order to develop new methods for the prevention, diagnosis and personalized treatment of diseases. The junior research groups will be located at the BIMSB where they have access to the latest single cell technologies and scientific expertise. At the same time, each junior research group will closely collaborate with a clinical department at the Charité to develop single cell approaches to address specific clinical issues and establish technologies for clinical use.
In a first step, twelve candidates were selected from among the applicants and invited to present their scientific work and project ideas for the focus area at a public recruitment symposium on February 6, 2020. The invited scientists come from renowned institutions in Germany, Israel, Sweden, Switzerland, the UK and the USA. In 30 minute talks they will present their expertise in single cell molecular profiling, cell lineage tracing and single cell multi omics approaches and their application in studying human health and disease.
The recruitment symposium also constitutes the scientific kick-off for the work of the new focus area. Researchers, clinicians and interested parties from BIH, MDC/BIMSB and Charité and elsewhere are warmly invited to come together to exchange information, network and plan joint projects
Lorenz Adlung (Weizmann Institute of Science, Israel)
Julia Cordero (University of Glasgow, UK)
Stefanie Grosswendt (MPI for Molecular Genetics, Germany)
Simon Haas (HI-STEM & DKFZ, Germany)
Laleh Haghverdi (EMBL Heidelberg, Germany)
Aleksandra Kolodziejczyk (Weizmann Institute of Science, Israel)
Dirk Löffler (ETH Zürich, Switzerland)
Leif Ludwig (Broad Institute of MIT and Harvard, USA)
Sueli Marques Spencer (Karolinska Institute, Sweden)
Benjamin Ostendorf (Rockefeller University, USA)
Alejo Rodriguez-Fraticelli (Boston Children’s Hospital, USA)
Ashley Sanders (EMBL Heidelberg, Germany)